BRAINSTORM CELL THERAPEUTICS INC. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q1 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q1 2011 to Q4 2023.
  • Brainstorm Cell Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending December 31, 2023 was $196K, a 81.1% decline year-over-year.
  • Brainstorm Cell Therapeutics Inc. Net Cash Provided by (Used in) Investing Activities for the twelve months ending December 31, 2023 was $2.19M, a 120% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was $2.19M, a 120% increase from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $998K, a 209% increase from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $323K.
Net Cash Provided by (Used in) Investing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $2.19M $196K -$842K -81.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $3.04M -$12K -$1K -9.09% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $3.04M $4K +$16K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $3.02M $2.01M +$2.02M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $998K $1.04M +$2.34M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$1.34M -$11K -$1.71M -101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $370K -$12K +$27K +69.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $343K -$17K +$20K +54.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $323K -$1.3M -$995K -329% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $1.32M $1.7M +$1.78M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$464K -$39K +$2.03M +98.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2.5M -$37K +$1.96M +98.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$4.45M -$302K +$43K +12.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 -$4.5M -$86K -$1.53M -106% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.97M -$2.07M -$3.46M -249% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $491K -$1.99M -$5.13M -164% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-26
Q4 2019 $5.62M -$345K -$4.31M -109% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-04
Q3 2019 $9.93M $1.44M -$3.54M -71.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-15
Q2 2019 $13.5M $1.39M +$14.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 -$951K $3.13M +$267K +9.32% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$1.22M $3.97M +$1.22M +44.6% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-18
Q3 2018 -$2.44M $4.98M +$12.2M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$14.7M -$13M -$19.8M -292% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $5.15M $2.86M +$1.17M +68.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $3.99M $2.75M Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-01
Q3 2017 -$7.24M Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $6.78M Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 $1.7M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q1 2015 -$17.9M -$13.6M -$13.5M -15859% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-14
Q4 2014 -$4.45M -$2.76M -$7.54M -158% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-26
Q3 2014 $3.09M -$1.61M +$1.43M +47.2% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-13
Q2 2014 $1.66M -$2K* +$55K Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $1.6M -$85K -$1.06M -109% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $2.66M $4.78M +$7.55M Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 -$4.89M -$3.04M -$3.03M -21607% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$1.87M -$57K -$48K -533% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$1.82M $971K +$1.02M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 -$2.84M -$2.77M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-27
Q3 2012 -$14K -$13K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$9K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$52K -$16K -44.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q3 2011 -$1K* Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q1 2011 -$36K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.